Monte Rosa Therapeutics Inc (GLUE)

NASDAQ
23.88
-1.04(-4.17%)
  • Volume:
    107,324
  • Bid/Ask:
    15.11/26.00
  • Day's Range:
    23.31 - 24.86

GLUE Overview

Prev. Close
24.92
Day's Range
23.31-24.86
Revenue
-
Open
24.4
52 wk Range
18.01-45.56
EPS
-
Volume
107,324
Market Cap
1.08B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
261,405
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
45,025,857
Next Earnings Date
Dec 01, 2021
What is your sentiment on Monte Rosa Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Monte Rosa Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

Monte Rosa Therapeutics Inc Company Profile

Monte Rosa Therapeutics Inc Company Profile

Sector
Services
Employees
60

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn’s disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is based in Boston, Massachusetts.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.